By Maggie Fick LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on ...

Every drug cartel needs someone to do the money laundering. The perfectly legal drug industry known as Big Pharma channels ...

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...

Nischal Maheshwari, CEO and Market Expert, feels the market is close to the bottom and expects clarity post the resolution of ...

In the week when U.S. President Donald Trump sounded alarm bells about Ireland “stealing the U.S. pharmaceutical industry” ...

The first round of $175,000 in Big Pharma funds goes to local agencies devoted to education, prevention, intervention, harm ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...

Shore Capital, which covers hVIVO, sees plenty of upside. The broker notes that the company’s cash generation, revenue visibility, and profitability make it an outlier in healthcare, where many firms ...

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, is more optimistic about the market after the correction. He believes ...